NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market on Wednesday that its first quarter revenues rose 28 percent on the strength of its reproductive health diagnostics business.

For the quarter ended March 31, the molecular diagnostics developer reported revenues of $3.0 million, up from $2.3 million a year ago.

Diagnostics services revenues made up $2.9 million of the total, a 26 percent increase over the $2.3 million the company reported in Q1 2015. Revenues from royalties totaled $42,000 for the quarter, flat with the year-ago period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.